Top compounds associated with response to SPRY1


Feature Type Standardized
Nominal ANOVA
mRNA PLX4720 CCLE pan-cancer AAC 0.14 0.002
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA ouabain CTRPv2 pan-cancer AAC 0.11 0.003
mRNA BRD-K63431240 CTRPv2 pan-cancer AAC 0.11 0.003
mRNA Crizotinib GDSC1000 pan-cancer AAC 0.17 0.003
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.098 0.003
mRNA SL 0101-1 GDSC1000 pan-cancer AAC 0.11 0.004
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.004
mRNA Nilotinib CCLE pan-cancer AAC 0.15 0.004
mRNA VX-11e GDSC1000 pan-cancer AAC 0.099 0.005
Download CSV